ConductScience.org, home

Paper20108024

Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation.

Suda K and 2 others. Cancer Metastasis Rev, 2010. Cited by 182 papers, by iCite.

Cite this record

ConductScience Library. Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation. Papers, record 20108024. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20108024

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation.
PubMed
Journal
Cancer Metastasis Rev
PubMed
Year
2010
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
182
iCite
Relative citation ratio, by iCite
4.13
iCite
Revised in PubMed
2022-04-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Suda KKenichi
2Tomizawa KKenji
3Mitsudomi TTetsuya

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Cell Transformation, NeoplasticMajor topic
Genes, erbB-1Major topic
Genes, rasMajor topic
Lung NeoplasmsMajor topic
MutationMajor topic
Animals
Gene Expression Regulation, Neoplastic
Humans
Models, Biological
Transcriptional Activation

Source PubMed

Download CSV of topics

Cited by96

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 182 citations.

PMIDTitleJournalYearIn PapersSource
42511913Unsupervised Deep Representation Learning and Probabilistic Clustering for the Systems-Level Discovery of Germline Mutation Signatures in Pediatric Cancers.Biomedicines2026https://conductscience.org/library/papers/42511913PubMed
41963365Extracellular matrix-driven patient stratification and network modeling reveal distinct molecular grades with potential clinical implications.NPJ Syst Biol Appl2026https://conductscience.org/library/papers/41963365PubMed
41595602A Multikinase Inhibitor AX-0085 Blocks FGFR1 Activation to Overcomes Osimertinib Resistance in Non-Small Cell Lung Cancer.Biomedicines2025https://conductscience.org/library/papers/41595602PubMed
41509216Revealing the Drivers Underlying Distinct Evolutionary Trajectories in Lung Adenocarcinoma.bioRxiv2025https://conductscience.org/library/papers/41509216PubMed
41162968BRCAGenie: A machine learning-driven 43-gene polygenic risk score model for precision prediction of breast cancer survival.J Transl Med2025https://conductscience.org/library/papers/41162968PubMed
41031439Fraternal cooperation of hierarchical cancer parallels metazoan multicellularity and eusociality.Biol Rev Camb Philos Soc2026https://conductscience.org/library/papers/41031439PubMed
41002380TIMP-1 Modulation Correlates with KRAS Dependency and EMT Induction in NSCLC.Cells2025https://conductscience.org/library/papers/41002380PubMed
40282505Alternative Splicing in Lung Adenocarcinoma: From Bench to Bedside.Cancers (Basel)2025https://conductscience.org/library/papers/40282505PubMed
40218244Lung Adenocarcinoma Exhibiting Thanatosomes (Hyaline Bodies), Cytoplasmic Clearing, and Nuclear Pleomorphism, with a KRAS Mutation.Diagnostics (Basel)2025https://conductscience.org/library/papers/40218244PubMed
39926430Gene mutation in diabetic patients with lung adenocarcinoma: a real-world retrospective cohort study.Front Med (Lausanne)2025https://conductscience.org/library/papers/39926430PubMed
39203962Tumor Neoepitope-Based Vaccines: A Scoping Review on Current Predictive Computational Strategies.Vaccines (Basel)2024https://conductscience.org/library/papers/39203962PubMed
39123454
Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as Potential New Biomarkers in Patients with Diabetes Mellitus and Pancreatic Adenocarcinoma.
Cancers (Basel)2024https://conductscience.org/library/papers/39123454PubMed
38098505The development of cancers research based on mitochondrial heat shock protein 90.Front Oncol2023https://conductscience.org/library/papers/38098505PubMed
37508774An Explainable Radiogenomic Framework to Predict Mutational Status of KRAS and EGFR in Lung Adenocarcinoma Patients.Bioengineering (Basel)2023https://conductscience.org/library/papers/37508774PubMed
37213670Synergistic Effect of Metformin and Lansoprazole Against Gastric Cancer through Growth Inhibition.Int J Med Sci2023https://conductscience.org/library/papers/37213670PubMed
36528578Effect of EGFR amplification on the prognosis of EGFR-mutated advanced non-small-cell lung cancer patients: a prospective observational study.BMC Cancer2022https://conductscience.org/library/papers/36528578PubMed
36330448KRAS is a prognostic biomarker associated with diagnosis and treatment in multiple cancers.Front Genet2022https://conductscience.org/library/papers/36330448PubMed
36238300Predictive mutation signature of immunotherapy benefits in NSCLC based on machine learning algorithms.Front Immunol2022https://conductscience.org/library/papers/36238300PubMed
36004014KRAS G12C-Mutant Non-Small-Cell Lung Adenocarcinoma: First Documented Report in the Arabian Gulf.Cureus2022https://conductscience.org/library/papers/36004014PubMed
35441145Development of a NanoBRET assay to validate inhibitors of Sirt2-mediated lysine deacetylation and defatty-acylation that block prostate cancer cell migration.RSC Chem Biol2022https://conductscience.org/library/papers/35441145PubMed

See all 96 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
KRAS3845PubTator's text mininghttps://conductscience.org/library/genes/3845NCBI Gene
TXK7294PubTator's text mininghttps://conductscience.org/library/genes/7294NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20108024

GET https://conductscience.org/api/papers/v1/20108024/cited_by?page=2